• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity.

作者信息

Persson E, Bak H, Olsen O H

机构信息

Vascular Biochemistry, Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark.

出版信息

J Biol Chem. 2001 Aug 3;276(31):29195-9. doi: 10.1074/jbc.M102187200. Epub 2001 Jun 1.

DOI:10.1074/jbc.M102187200
PMID:11389142
Abstract

Factor VII requires the cleavage of an internal peptide bond and the association with tissue factor (TF) to attain its fully active factor VIIa (FVIIa) conformation. The former event alone leaves FVIIa in a zymogen-like state of relatively low specific activity. We have designed a number of FVIIa mutants with the aim of mimicking the effect of TF, that is, creating molecules with increased intrinsic (TF-independent) enzymatic activity. Based on a possible structural difference between free and TF-bound FVIIa (Pike, A. C. W., Brzozowski, A. M., Roberts, S. M., Olsen, O. H., and Persson, E. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 8925--8930), we focused on the helical region encompassing residues 307-312 and residues in its spatial vicinity. For instance, FVIIa contains Phe-374 and Leu-305, whereas a Phe/Tyr residue in the position corresponding to 374 in homologous coagulation serine proteases is accompanied by Val in the position corresponding to 305. This conceivably results in a unique orientation of this helix in FVIIa. Substitution of Val for Leu-305 in FVIIa resulted in a 3--4-fold increase in the intrinsic amidolytic and proteolytic activity as compared with wild-type FVIIa, whereas the activity in complex with soluble TF remained the same. In accordance with this, L305V-FVIIa exhibited an increased rate of inhibition as compared with wild-type FVIIa, both by d-Phe-Phe-Arg-chloromethyl ketone and antithrombin III in the presence of heparin. The increased FVIIa activity upon replacement of Leu-305 by Val may be mediated by a movement of the 307--312 helix into an orientation resembling that found in factors IXa and Xa and thrombin. The corresponding shortening of the side chain of residue 374 (Phe --> Pro) had a smaller effect (about 1.5-fold increase) on the intrinsic activity of FVIIa. Attempts to increase FVIIa activity by introducing single or multiple mutations at positions 306, 309, and 312 to stabilize the 307-312 helix failed.

摘要

相似文献

1
Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity.
J Biol Chem. 2001 Aug 3;276(31):29195-9. doi: 10.1074/jbc.M102187200. Epub 2001 Jun 1.
2
Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.防止β链移动到类似酶原的位置并不能赋予凝血因子VIIa更高的活性。
Biochemistry. 2004 Nov 9;43(44):14096-103. doi: 10.1021/bi048721o.
3
Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.在因子VIIa中,将天冬氨酸替代甲硫氨酸-306会消除活性位点与组织因子结合界面之间的变构联系。
Biochemistry. 2001 Mar 20;40(11):3251-6. doi: 10.1021/bi001612z.
4
Assignment of molecular properties of a superactive coagulation factor VIIa variant to individual amino acid changes.
Eur J Biochem. 2002 Dec;269(23):5950-5. doi: 10.1046/j.1432-1033.2002.03323.x.
5
Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement.通过替换305、314、337和374位残基增强因子VIIa的内在活性:两种独特的活性增强突变机制的证据。
Biochem J. 2004 Apr 15;379(Pt 2):497-503. doi: 10.1042/BJ20031596.
6
Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.具有受限β-链构象的凝血因子VIIa二硫键锁定变体具有增强的酶活性。
Protein Sci. 2005 May;14(5):1171-80. doi: 10.1110/ps.041097505.
7
Factor VII mutant V154G models a zymogen-like form of factor VIIa.因子 VII 突变体 V154G 模拟了因子 VIIa 的酶原样形式。
Biochem J. 2003 Feb 1;369(Pt 3):563-71. doi: 10.1042/BJ20020888.
8
Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.以其人之道还治其人之身:可溶性非组织因子依赖的凝血因子VIIa的设计与特性
J Biol Chem. 2020 Jan 10;295(2):517-528. doi: 10.1074/jbc.RA119.009183. Epub 2019 Dec 4.
9
Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.激活环3与170环在凝血因子VIIa的活性构象中相互作用。
FEBS J. 2009 Jun;276(11):3099-109. doi: 10.1111/j.1742-4658.2009.07028.x. Epub 2009 Apr 23.
10
Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.组织因子会改变具有催化重要性的因子VIIa残基的pK(a)值。
Biochemistry. 2002 Mar 12;41(10):3364-71. doi: 10.1021/bi0110847.

引用本文的文献

1
A bipolar disorder-associated missense variant alters adenylyl cyclase 2 activity and promotes mania-like behavior.一种与双相情感障碍相关的错义变异改变了腺苷酸环化酶2的活性并促进类似躁狂的行为。
Mol Psychiatry. 2025 Jan;30(1):97-110. doi: 10.1038/s41380-024-02663-w. Epub 2024 Jul 13.
2
Active antithrombin glycoforms are selectively physiosorbed on plasma extracellular vesicles.活性抗凝血酶糖型被选择性地物理吸附在血浆细胞外囊泡上。
J Extracell Biol. 2022 Sep 23;1(9):e57. doi: 10.1002/jex2.57. eCollection 2022 Sep.
3
Antithrombin III levels in critically ill surgical patients: do they correlate with VTE?
重症外科患者的抗凝血酶III水平:它们与静脉血栓栓塞症有关吗?
Trauma Surg Acute Care Open. 2023 Jun 14;8(1):e001009. doi: 10.1136/tsaco-2022-001009. eCollection 2023.
4
A systematic approach for evaluating the role of surface-exposed loops in trypsin-like serine proteases applied to the 170 loop in coagulation factor VIIa.一种评估表面暴露环在类胰蛋白酶丝氨酸蛋白酶中作用的系统方法,应用于凝血因子VIIa的170环。
Sci Rep. 2022 Mar 8;12(1):3747. doi: 10.1038/s41598-022-07620-7.
5
Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.以其人之道还治其人之身:可溶性非组织因子依赖的凝血因子VIIa的设计与特性
J Biol Chem. 2020 Jan 10;295(2):517-528. doi: 10.1074/jbc.RA119.009183. Epub 2019 Dec 4.
6
Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanism.一种针对超活性FVIIa的抗体的晶体结构、表位及功能影响为变构机制提供了见解。
Res Pract Thromb Haemost. 2019 Jun 20;3(3):412-419. doi: 10.1002/rth2.12211. eCollection 2019 Jul.
7
Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity.因子 IX Padua(R338L)的过度活跃依赖于因子 VIIIa 辅因子活性。
JCI Insight. 2019 Jun 20;5(14):128683. doi: 10.1172/jci.insight.128683.
8
Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides.具有高甘露糖型或复杂型非岩藻糖基化N-连接寡糖的人抗凝血酶生物活性比较。
Glycobiology. 2016 May;26(5):482-92. doi: 10.1093/glycob/cww001. Epub 2016 Jan 7.
9
Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways.抗体通过不同的变构途径增强因子 VIIa 的活性。
J Biol Chem. 2012 Mar 16;287(12):8994-9001. doi: 10.1074/jbc.M111.312330. Epub 2012 Jan 24.
10
Genetic diversity of the sulfotransferase-like gene and one nonsynonymous SNP associated with growth traits of clam, Meretrix meretrix.贻贝生长性状相关的磺基转移酶样基因遗传多样性及一个非同义 SNP 分析。
Mol Biol Rep. 2012 Feb;39(2):1323-31. doi: 10.1007/s11033-011-0865-4. Epub 2011 May 20.